12:00 AM
 | 
Jun 16, 1997
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Amur Pharmaceuticals preclinical data

At the Endocrine Society Meeting in Minneapolis, Amur described the isolation of dehidroepiandrosterone conjugated with phosphocholine (DHEA-PC) and its ability to modulate immune function.

Normal mice were immunologically challenged with 2 percent dinitrochlorobenzene applied to the skin on the back. DHEA-PC or dexamethasone was injected subcutaneously at...

Read the full 216 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >